ETF Chart of the Day: Biotechnology Breakthroughs

Yesterday we spoke about the U.S. Biotech Equity sector generally, specifically in terms of impressive net inflows in 2015 as well as in the short term in IBB (iShares NASDAQ Biotechnology, Expense Ratio 0.48%) and other names in the category. This brings us today to examine an ETF that debuted on...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.